We are international
Donate
• videos TEXT SIZE   
imf international webcasts    back

Problemi legati alla terapia
Tommaso Caravita (Rome)
12.20.09
Problemi legati alla terapia

To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related videos
ASH 2010 Overview fr...
Bildgebung beim Mult...
Bisphophonate - Ba...
Cos'è un prot...
Discussione -1
Discussione - 2
Discussione - 3
Dr. Bladé - A...
Dr. Bladé - U...
Dr. Cavo - Bortezomi...
Dr. Dispenzieri - A ...
Dr. Jagannath - Long...
Dr. Krishnan - Tande...
Dr. Kumar - Efficacy...
Dr. Kumar - Novel Th...
Dr. Kumar - Phase 1 ...
Dr. Lacy - Pomalidom...
Dr. Leleu - MELISSE,...
Dr. Lonial - Elotuzu...
Dr. Ludwig - Ein Übe...
Dr. Ludwig - The Rat...
Dr. Martin - Baselin...
Dr. San Miguel- Un r...
Dr. Sher - Efficacy ...
Dr. Sher - Phase I S...
Dr. Siegel - Outcome...
Dr. Siegel - Vorinos...
Dr. Stewart - A Rand...
Dr. Suvannasankha - ...
Dr. Suvannasankha - ...
Dr. Van Ness - Ident...
Dr. Waage - En overs...
video
Il Consenso Informat...
Il Ruolo dell'Inferm...
Bone Disease in Myel...
Knochenmarkdiagnosti...
La Terapia
La Terapia
La Terapia
La terapia del pazie...
La terapia del pazie...
Los Angeles Patient ...
Los Angeles Patient ...
Malen als Therapie
Lonial
Multiples Myelom - G...
Multiples Myelom: Wa...
Neue Klassifikatione...
Neue Substanzen in d...
Neue Substanzen: Zuk...
Onkologische Nachsor...
Overview of ASH 2010
Allogreff de cellule...
Paris 2009 Séminaire...
Questions et R&eacut...
Traitement de premi&...
Problemi legati alla...
Selbsthilfe und ihre...
Welcome and Introduc...
עדכון מאש 2009

 related articles
ASH 2010 Overview fr...
Ask-the-ExpertsOpen ...
Bildgebung beim Mult...
BisphophonateBallon ...
Bone Disease in Mult...
Cos'è un prot...
Discussione - 1
Discussione - 2
Discussione - 3
Dr. Bladé - A...
Dr. Bladé - U...
Dr. Cavo - Bortezomi...
Dr. Dispenzieri - A ...
Dr. Jagannath - Long...
Dr. Krishnan - Tande...
Dr. Kumar - Efficacy...
Dr. Kumar - Novel Th...
Dr. Kumar - Phase 1 ...
Dr. Lacy - Pomalidom...
Dr. Leleu - MELISSE,...
Dr. Lonial - Elotuzu...
Dr. Ludwig - Ein Übe...
Dr. Ludwig - The Rat...
Dr. Martin - Baselin...
Dr. San Miguel- Un r...
Dr. Sher - Efficacy ...
Dr. Sher - Phase I S...
Dr. Siegel - Outcome...
Dr. Siegel - Vorinos...
Dr. Stewart - A Rand...
Dr. Suvannasankha - ...
Dr. Suvannasankha - ...
Dr. Van Ness - Ident...
Dr. Waage - En overs...
How to Be a Good Pat...
Il Consenso Informat...
Il Ruolo dell'Inferm...
IMF AdvocacyGreg Bro...
Introduction and Bon...
Knochenmarkdiagnosti...
La Terapia
La Terapia
La Terapia
La terapia del pazie...
La terapia del pazie...
Los Angeles Patient ...
Los Angeles Patient ...
Malen als Therapie
Managing the Side ef...
Multiple Myeloma: Re...
Multiples Myelom - G...
Multiples Myelom: Wa...
Myeloma 101/Overview...
Neue Klassifikatione...
Neue Substanzen in d...
Neue Substanzen: Zuk...
Onkologische Nachsor...
Options for Frontlin...
Overview of ASH 2010
Paris 2009 Séminaire...
Paris 2009 Séminaire...
Paris 2009 Séminaire...
Paris 2009 Séminaire...
Problemi legati alla...
Role of Bone Marrow ...
Selbsthilfe und ihre...
The Small PrintDr. B...
Understanding Scient...
Understanding Serum ...
Welcome and Introduc...
עדכון מאש 2009

ASH 2010 Overview from Dr. Kenneth Anderson
Bildgebung beim Multiplen Myelom
"MRT/CT/Röntgen - wann indiziert?"
Bisphophonate - Ballon Kyphoplastie
Cos'è un protocollo clinico - rispondono data managers and research nurses
Discussione -1
Discussione - 2
Discussione - 3
Dr. Bladé - A Phase III PETHEMA/GEM Study of Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) In Multiple Myeloma: Superiority of VTD (Bortezomib/Thalidomide/Dexamethasone) Over TD and VBMCP/VBAD Plus Bortezomib
Dr. Bladé - Un resumen de las presentaciones de ASH 2010
Dr. Cavo - Bortezomib-Thalidomide-Dexamethasone Compared with Thalidomide-Dexamethasone as Induction and Consolidation Therapy Before and After Double Autologous Transplantation In Newly Diagnosed Multiple Myeloma: Results From a Randomized Phase 3 Study
Dr. Dispenzieri - A Phase-2 Study of Pomalidomide and Dexamethasone In Previously-Treated Light-Chain (AL) Amyloidosis
Dr. Jagannath - Long-Term Treatment and Tolerability of the Novel Proteasome Inhibitor Carfilzomib (CFZ) In Patients with Relapsed and/or Refractory Multiple Myeloma (R/R MM)
Dr. Krishnan - Tandem Autologous Hematopoietic Stem Cell Transplants (AuHCT) with or without Maintenance Therapy (auto-auto) Versus Single AuHCT Followed by HLA Matched Sibling Non- Myeloablative Allogeneic HCT (auto-allo) for Patients with Standard Risk (SR) Multiple Myeloma (MM): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial
Dr. Kumar - Efficacy of Retreatment with Immunomodulatory Compounds In Patients Receiving Initial Therapy for Newly Diagnosed Multiple Myeloma
Dr. Kumar - Novel Three- and Four-Drug Combination Regimens of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Previously Untreated Multiple Myeloma: Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study
Dr. Kumar - Phase 1 Trial of Sorafenib and Everolimus In Patients with Lymphoma or Multiple Myeloma
Dr. Lacy - Pomalidomide Plus Low-Dose Dexamethasone In Myeloma Refractory to Both Bortezomib and Lenalidomide: Comparison of Two Dosing Strategies In Dual-Refractory Disease
Dr. Leleu - MELISSE, a Large Multicentric Observational Study to Determine Criteria and Risk Factors of Thromboembolism for Patients with Multiple Myeloma Treated with Immunomodulator Drugs
Dr. Lonial - Elotuzumab In Combination with Lenalidomide and Low-Dose Dexamethasone In Patients with Relapsed/Refractory Multiple Myeloma: Interim Results of a Phase 1 Study
Dr. Ludwig - Ein Überblick über den ASH-Kongress 2010
Dr. Ludwig - The Ratio of Monoclonal to Polyclonal Immunoglobulins Assessed with the Hevylite Test Predicts Prognosis, Is Superior for Monitoring the Course of the Disease and Allows Detection of Monoclonal Immunoglobulin In Patients with Normal or Subnormal Involved Immunoglobulin Isotype
Dr. Martin - Baseline Peripheral Neuropathy Does Not Impact the Efficacy and Tolerability of the Novel Proteasome Inhibitor Carfilzomib (CFZ): Results of a Subset Analysis of a Phase 2 Trial In Patients with Relapsed and Refractory Multiple Myeloma (R/R MM)
Dr. San Miguel- Un resumen de las presentaciones de ASH 2010
Dr. Sher - Efficacy Analysis From Phase I Study of Lorvotuzumab Mertansine (IMGN901), Used as Monotherapy, In Patients with Heavily Pre-Treated CD56-Positive Multiple Myeloma - A Preliminary Efficacy Analysis
Dr. Sher - Phase I Study of Lorvotuzumab Mertansine (IMGN901) In Combination with Lenalidomide and Dexamethasone In Patients with CD56-Positive Relapsed or Relapsed/Refractory Mulitple Myeloma - A Preliminary Safety and Efficacy Analysis of the Combination
Dr. Siegel - Outcome with Lenalidomide Plus Dexamethasone Followed by Early Autologous Stem Cell Transplantation In the ECOG E4A03 Randomized Clinical Trial
Dr. Siegel - Vorinostat Overcomes Lenalidomide-Dexamethasone and Lenalidomide-Bortezomib-Dexamethasone Resistance In Relapsed/Refractory Multiple Myeloma
Dr. Stewart - A Randomized Phase III Trial of Thalidomide and Prednisone as Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT) In Patients with Multiple Myeloma (MM): The NCIC CTG MY.10 Trial
Dr. Suvannasankha - Assessment of the Performance of Serum Heavy Chains Immunoassay to Monitor Response to Treatment and Its Correlation with Other Tumor Measurements In Serial Samples From Patients with Newly Diagnosed MM
Dr. Suvannasankha - Phase 2 Clinical Trial of Oral Lenalidomide, Cyclophosphamide, and Prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients
Dr. Van Ness - Identification of Single Nucleotide Polymorphism Interactions Associated with Survival and Risk In Multiple Myeloma Using Novel Data Mining Methods
Dr. Waage - En oversikt over ASH 2010
video
Il Consenso Informato
Il Ruolo dell'Infermiere in un D.H. di Ematologia: Procedura per Infusione Bortezomib
Bone Disease in Myeloma
Knochenmarkdiagnostik
muß dies sein
La Terapia
La Terapia
La Terapia
La terapia del paziente giovane
La terapia del paziente giovane
Los Angeles Patient & Family Seminar
August 28, 2010
Los Angeles Patient & Family Seminar
August 28, 2010
Malen als Therapie
Lonial
Multiples Myelom - Grundbegriffe
Multiples Myelom: Wann behandeln? Wie kontrollieren?
Neue Klassifikationen des Multiplen Myeloms - Welche Relevanz haben sie für den Patienten?
Neue Substanzen in der Therapie des Multiplen Myeloms
Neue Substanzen: Zukunftsperspektiven in der Therapie des Multiplen Myeloms
Onkologische Nachsorge Psychologische Betreuung für Patienten & Angehörige
Overview of ASH 2010
Allogreff de cellules souches hématopoïétiques
Prof. Jean-Luc Harousseau
Paris 2009 Séminaire - Evolution de la prise en charge du sujet jeune
Questions et Réponses
Traitement de première ligne du myélome multiple chez les patients non éligibles au traitement intensif avec autogreff de CSH
Problemi legati alla terapia
Selbsthilfe und ihre Bedeutung
Welcome and Introductions
עדכון מאש 2009
ASH 2010 Overview from Dr. Kenneth Anderson
Ask-the-Experts
Open Forum Discussion with Dr. Brian G.M. Durie, Dr. Frederick Smith and Dr. Robert Kyle
Bildgebung beim Multiplen Myelom
"MRT/CT/Röntgen - wann indiziert?"
Bisphophonate
Ballon Kyphoplastie
Bone Disease in Multiple Myeloma
Dr. Brian Durie
Cos'è un protocollo clinico - rispondono data managers and research nurses
Discussione - 1
Discussione - 2
Discussione - 3
Dr. Bladé - A Phase III PETHEMA/GEM Study of Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) In Multiple Myeloma: Superiority of VTD (Bortezomib/Thalidomide/Dexamethasone) Over TD and VBMCP/VBAD Plus Bortezomib
Dr. Bladé - Un resumen de las presentaciones de ASH 2010
Dr. Cavo - Bortezomib-Thalidomide-Dexamethasone Compared with Thalidomide-Dexamethasone as Induction and Consolidation Therapy Before and After Double Autologous Transplantation In Newly Diagnosed Multiple Myeloma: Results From a Randomized Phase 3 Study
Dr. Dispenzieri - A Phase-2 Study of Pomalidomide and Dexamethasone In Previously-Treated Light-Chain (AL) Amyloidosis
Dr. Jagannath - Long-Term Treatment and Tolerability of the Novel Proteasome Inhibitor Carfilzomib (CFZ) In Patients with Relapsed and/or Refractory Multiple Myeloma (R/R MM)
Dr. Krishnan - Tandem Autologous Hematopoietic Stem Cell Transplants (AuHCT) with or without Maintenance Therapy (auto-auto) Versus Single AuHCT Followed by HLA Matched Sibling Non- Myeloablative Allogeneic HCT (auto-allo) for Patients with Standard Risk (SR) Multiple Myeloma (MM): Results From the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0102 Trial
Dr. Kumar - Efficacy of Retreatment with Immunomodulatory Compounds In Patients Receiving Initial Therapy for Newly Diagnosed Multiple Myeloma
Dr. Kumar - Novel Three- and Four-Drug Combination Regimens of Bortezomib, Dexamethasone, Cyclophosphamide, and Lenalidomide, for Previously Untreated Multiple Myeloma: Results From the Multi-Center, Randomized, Phase 2 EVOLUTION Study
Dr. Kumar - Phase 1 Trial of Sorafenib and Everolimus In Patients with Lymphoma or Multiple Myeloma
Dr. Lacy - Pomalidomide Plus Low-Dose Dexamethasone In Myeloma Refractory to Both Bortezomib and Lenalidomide: Comparison of Two Dosing Strategies In Dual-Refractory Disease
Dr. Leleu - MELISSE, a Large Multicentric Observational Study to Determine Criteria and Risk Factors of Thromboembolism for Patients with Multiple Myeloma Treated with Immunomodulator Drugs
Dr. Lonial - Elotuzumab In Combination with Lenalidomide and Low-Dose Dexamethasone In Patients with Relapsed/Refractory Multiple Myeloma: Interim Results of a Phase 1 Study
Dr. Ludwig - Ein Überblick über den ASH-Kongress 2010
Dr. Ludwig - The Ratio of Monoclonal to Polyclonal Immunoglobulins Assessed with the Hevylite Test Predicts Prognosis, Is Superior for Monitoring the Course of the Disease and Allows Detection of Monoclonal Immunoglobulin In Patients with Normal or Subnormal Involved Immunoglobulin Isotype
Dr. Martin - Baseline Peripheral Neuropathy Does Not Impact the Efficacy and Tolerability of the Novel Proteasome Inhibitor Carfilzomib (CFZ): Results of a Subset Analysis of a Phase 2 Trial In Patients with Relapsed and Refractory Multiple Myeloma (R/R MM)
Dr. San Miguel- Un resumen de las presentaciones de ASH 2010
Dr. Sher - Efficacy Analysis From Phase I Study of Lorvotuzumab Mertansine (IMGN901), Used as Monotherapy, In Patients with Heavily Pre-Treated CD56-Positive Multiple Myeloma - A Preliminary Efficacy Analysis
Dr. Sher - Phase I Study of Lorvotuzumab Mertansine (IMGN901) In Combination with Lenalidomide and Dexamethasone In Patients with CD56-Positive Relapsed or Relapsed/Refractory Mulitple Myeloma - A Preliminary Safety and Efficacy Analysis of the Combination
Dr. Siegel - Outcome with Lenalidomide Plus Dexamethasone Followed by Early Autologous Stem Cell Transplantation In the ECOG E4A03 Randomized Clinical Trial
Dr. Siegel - Vorinostat Overcomes Lenalidomide-Dexamethasone and Lenalidomide-Bortezomib-Dexamethasone Resistance In Relapsed/Refractory Multiple Myeloma
Dr. Stewart - A Randomized Phase III Trial of Thalidomide and Prednisone as Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT) In Patients with Multiple Myeloma (MM): The NCIC CTG MY.10 Trial
Dr. Suvannasankha - Assessment of the Performance of Serum Heavy Chains Immunoassay to Monitor Response to Treatment and Its Correlation with Other Tumor Measurements In Serial Samples From Patients with Newly Diagnosed MM
Dr. Suvannasankha - Phase 2 Clinical Trial of Oral Lenalidomide, Cyclophosphamide, and Prednisone (RCP) for Newly Diagnosed Multiple Myeloma Patients
Dr. Van Ness - Identification of Single Nucleotide Polymorphism Interactions Associated with Survival and Risk In Multiple Myeloma Using Novel Data Mining Methods
Dr. Waage - En oversikt over ASH 2010
How to Be a Good Patient
Michael Katz
Il Consenso Informato
Il Ruolo dell'Infermiere in un D.H. di Ematologia: Procedura per Infusione Bortezomib
IMF Advocacy
Greg Brozeit with Christine Murphy and Arin Assero
Introduction and Bone Disease in Myeloma
Knochenmarkdiagnostik
muß dies sein
La Terapia
La Terapia
La Terapia
La terapia del paziente giovane
La terapia del paziente giovane
Los Angeles Patient & Family Seminar
August 28, 2010
Los Angeles Patient & Family Seminar
August 28, 2010
Malen als Therapie
Managing the Side effects of Novel Agents
Kena Miller,RN, MSN, FNP
Multiple Myeloma: Relapsed Disease
Dr. Sagar Lonial
Multiples Myelom - Grundbegriffe
Multiples Myelom: Wann behandeln? Wie kontrollieren?
Myeloma 101/Overview
Dr. Robert Kyle
Neue Klassifikationen des Multiplen Myeloms - Welche Relevanz haben sie für den Patienten?
Neue Substanzen in der Therapie des Multiplen Myeloms
Neue Substanzen: Zukunftsperspektiven in der Therapie des Multiplen Myeloms
Onkologische Nachsorge
Psychologische Betreuung für Patienten & Angehörige
Options for Frontline Therapy
Dr. Brian Durie
Overview of ASH 2010
Paris 2009 Séminaire - Allogreff de cellules souches hématopoïétiques
Paris 2009 Séminaire - Evolution de la prise en charge du sujet jeune
Paris 2009 Séminaire - Questions et Réponses
Paris 2009 Séminaire - Traitement de première ligne du myélome multiple chez les patients non éligibles au traitement intensif avec autogreff de CSH
Problemi legati alla terapia
Role of Bone Marrow Transplant in the Treatment of Myeloma
Dr. Edward A. Stadtmauer
Selbsthilfe und ihre Bedeutung
The Small Print
Dr. Brian Durie
Understanding Scientific Literature
Allan Weinstein, PhD
Understanding Serum Free Light Chain Assays
Dr. Karen Van Hoeven
Welcome and Introductions
עדכון מאש 2009